Cytosorbents Corporation
CTSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $14 | $22 | $52 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $6 | $6 | $5 |
| Inventory | $3 | $4 | $3 | $5 |
| Other Curr. Assets | $8 | $2 | $2 | $3 |
| Total Curr. Assets | $22 | $26 | $34 | $64 |
| Property Plant & Equip (Net) | $21 | $22 | $23 | $19 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $4 | $4 | $5 |
| Long-Term Investments | $0 | $1 | $2 | $2 |
| Tax Assets | $0 | $4 | $0 | $0 |
| Other NC Assets | $2 | -$4 | $0 | $0 |
| Total NC Assets | $26 | $28 | $29 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $47 | $53 | $63 | $90 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $3 |
| Short-Term Debt | $0 | $3 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $1 | $2 | $2 |
| Other Curr. Liab. | $6 | $6 | $6 | $8 |
| Total Curr. Liab. | $10 | $15 | $10 | $14 |
| LT Debt | $26 | $15 | $18 | $13 |
| Deferred Rev, NC | $0 | -$4 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $4 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $26 | $15 | $18 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $13 | $13 | $13 |
| Total Liabilities | $36 | $30 | $28 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$304 | -$283 | -$254 | -$221 |
| AOCI | $4 | $1 | $2 | $1 |
| Other Equity | $311 | $305 | $287 | $283 |
| Total Equity | $11 | $23 | $35 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $47 | $53 | $63 | $90 |
| Net Debt | $24 | $4 | -$4 | -$38 |